Your browser doesn't support javascript.
loading
Comparison of cervical cancer screening by self-sampling papillomavirus test versus pap-smear in underprivileged women in France.
Reques, Laura; Rolland, Camille; Lallemand, Anne; Lahmidi, Najat; Aranda-Fernández, Ezequiel; Lazzarino, Antonio; Bottero, Julie; Hamers, Françoise; Bergeron, Christine; Haguenoer, Ken; Launoy, Guy; Luhmann, Niklas.
  • Reques L; Médecins du Monde, 62 rue Marcadet, 75018, Paris, France. requeslaura@hotmail.com.
  • Rolland C; Médecins du Monde, 62 rue Marcadet, 75018, Paris, France.
  • Lallemand A; Médecins du Monde, 62 rue Marcadet, 75018, Paris, France.
  • Lahmidi N; Médecins du Monde, 62 rue Marcadet, 75018, Paris, France.
  • Aranda-Fernández E; Médecins du Monde, 62 rue Marcadet, 75018, Paris, France.
  • Lazzarino A; EPISTATA - Agency for Clinical Research and Medical Statistics, London, UK.
  • Bottero J; Unité de Maladies Infectieuses et Tropicales, Groupe Hospitalo-Universitaire Paris Seine St-Denis, AP-HP, Hôpital Jean Verdier, Bondy, France.
  • Hamers F; Santé Publique France (National Public Health Agency), Saint Maurice cedex, France.
  • Bergeron C; Laboratoire CERBA, Saint-Ouen-l'Aumône, France.
  • Haguenoer K; U1153, INSERM, Paris, France.
  • Launoy G; Cancer Screening Department, CHRU de Tours, 37000, Tours, France.
  • Luhmann N; Centre François Baclesse, INSERM, Avenue du Général Harris, 14076, Caen, France.
BMC Womens Health ; 21(1): 221, 2021 05 26.
Article en En | MEDLINE | ID: mdl-34039341
ABSTRACT

BACKGROUND:

The purpose of this study was to compare cervical cancer screening by pap smear (PS) versus preliminary HPV testing based on self-collected samples (SC-HPV).

METHODS:

Interventional study among underprivileged women from 25 to 65 years old in four French cities. The control group (CG) was referred for a PS. The experimental group (EG) conducted a SC-HPV test followed by a PS in case of positivity. Differences on screening completion and cytological abnormalities were analysed by logistic and Cox regression.

RESULTS:

383 women were assigned to the EG and 304 to the CG. The screening completion proportion was 39.5% in the CG compared to 71.3% in the EG (HR = 2.48 (CI 95% [1.99-3.08]; p < 0.001). The proportion of cytological abnormalities was 2.0% in the CG and 2.3% in the EG (OR = 1.20 (CI 95% [0.42-3.40]; p = 0.7). The proportion of participants lost to follow-up was 60.5% in the CG and 63.2% in the EG HPV positive (p = 0.18).

CONCLUSION:

Providing an SC-HPV-test increased the participation of underprivileged women in CCS. Nevertheless, the significant number of lost to follow-up in both groups can undermine the initial benefits of the strategy for HPV positive women. Registration Clinicaltrials.gov NCT03118258.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias del Cuello Uterino / Infecciones por Papillomavirus Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Adult / Aged / Female / Humans / Middle aged País como asunto: Europa Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias del Cuello Uterino / Infecciones por Papillomavirus Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Adult / Aged / Female / Humans / Middle aged País como asunto: Europa Idioma: En Año: 2021 Tipo del documento: Article